Contraception
RSSArticles
-
Using Etonogestrel Implants and LNG-IUDs Past FDA-approved Duration
In this small prospective cohort study, use of the etonogestrel implant and the levonorgestrel intrauterine device for an additional year past their FDA-approved duration was associated with an acceptably low failure rate.
-
Help young women transition to adult healthcare
Young women ages 18 to 25 represent a heterogeneous population transitioning from adolescence into adulthood who might present with unique issues and challenges, including a potential gap in healthcare after pediatric healthcare. The American College of Obstetrics and Gynecology has just released a committee opinion to help providers structure preventive healthcare visits to screen for health issues and counsel patients about a variety of health topics, including reproductive health.
-
Counsel women on how to cope with menopause’s vasomotor symptoms
New research indicates that frequent vasomotor symptoms associated with menopause could last more than seven years for many women.
-
How to get the message across to young men about using condoms consistently and correctly
When used consistently and correctly, latex condoms are effective at preventing sexually transmitted infections, including HIV.
-
Research eyes effect of body weight and BMI impact on emergency contraception
Results of a new statistical analysis of clinical data suggest a significant drop in the efficacy of levonorgestrel emergency contraceptive pills with increasing body weight.
-
Intrauterine device and implant are effective beyond use approved by the FDA
An initial analysis of data conducted by Washington University School of Medicine in St. Louis indicates that hormonal intrauterine devices and contraceptive implants remain highly effective one year beyond their approved duration of use.
-
Options Expand for Women: FDA Approves a New Intrauterine Device
A new option in intrauterine contraception has been approved: the LILETTA intrauterine device.
-
Weight Gain with Contraception
In this prospective cohort study, perceived weight gain was found to be an adequate predictor of actual weight gain. Depot medroxyprogesterone acetate and the contraceptive implant were associated with more weight gain than the copper IUD. -
Quality Family Planning (QFP) — Put it into practice
“Providing Quality Family Planning Services — Recommendations of CDC and the U.S. Office of Population Affairs” is the newest member in the “suite” of family planning recommendations from the Centers for Disease Control and Prevention. -
Use of Cervical Length and Fetal Fibronectin in Preterm Labor
SYNOPSIS: A large 10-center study has validated the concept of screening all patients who are presenting with preterm contractions in the third trimester with cervical length examinations by transvaginal sonography and using fetal fibronectin selectively only in those with cervical lengths between 1.5 and 3.0 cm.